Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medeze Group PCLBKK:MEDEZE -1.59%19 EV-to-FCF is 206.25 as of Sep. 16, 2026. GuruFocus rates BKK:MEDEZE with a GF Score™ of 19/100. The stock has 5 warning signs investors should review. Among 421 Healthcare Providers & Services companies, Medeze Group PCL ranks worse than 94.77% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Medeze Group PCL's Enterprise Value is ฿5,084.2 Mil.
Medeze Group PCL's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2026 was ฿24.7 Mil. Therefore, Medeze Group PCL's EV-to-FCF for today is 206.25.
The historical rank and industry rank for Medeze Group PCL's EV-to-FCF or its related term are showing as below:
BKK:MEDEZE'
s EV-to-FCF Range Over the Past 10 Years
Min: -333.93 Med: -61.85 Max: 270.8
Current: 214.91
During the past 3 years, the highest EV-to-FCF of Medeze Group PCL was 270.80. The lowest was -333.93. And the median was -61.85.
BKK:MEDEZE's EV-to-FCF is ranked worse than 94.77% of 421
companies
in the Healthcare Providers & Services industry
Industry Median: 17.49
vs BKK:MEDEZE: 214.91
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Medeze Group PCL (BKK:MEDEZE) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Medeze Group PCL's PE Ratio (TTM) for today is calculated as:
Medeze Group PCL's share price for today is ฿6.20.
Medeze Group PCL's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿0.133.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Medeze Group PCL EV-to-FCF Related Terms
Medeze Group PCL EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Medeze Group PCL's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Medeze Group PCL's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medeze Group PCL EV-to-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Medeze Group PCL's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Medeze Group PCL's EV-to-FCF falls into.
Medeze Group PCL's current Enterprise Value is ฿5,084.2 Mil.
Medeze Group PCL's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿24.7 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medeze Group PCL (BKK:MEDEZE) has a EV-to-FCF of 206.25 as of Sep. 16, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Medeze Group PCL and its competitors. According to the industry distribution chart, Medeze Group PCL ranks #399 out of 421 companies in the Healthcare Providers & Services industry, placing it in the top 94.8%.
Is Medeze Group PCL's EV-to-FCF too high?
Medeze Group PCL's current EV-to-FCF is 206.25. The Healthcare Providers & Services industry median EV-to-FCF is 17.49. Medeze Group PCL's value of 206.25 is 1079.2% above this industry median. Based on the distribution chart, Medeze Group PCL ranks #399 out of 421 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Medeze Group PCL has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Medeze Group PCL's EV-to-FCF compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Medeze Group PCL ranks #399 out of 421 companies for EV-to-FCF. This places Medeze Group PCL in the lower half of its industry. The industry median EV-to-FCF is 17.49. Medeze Group PCL's value of 206.25 is 1079.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Healthcare Providers & Services company?
The median EV-to-FCF among Healthcare Providers & Services companies is 17.49, based on 421 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medeze Group PCL's current EV-to-FCF of 206.25 is 1079.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Medeze Group PCL and its competitors. For the Healthcare Providers & Services industry, the median EV-to-FCF is 17.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medeze Group PCL's current EV-to-FCF is 206.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medeze Group PCL stock overvalued right now?
Medeze Group PCL (BKK:MEDEZE) has a current EV-to-FCF of 206.25. The current EV-to-FCF is 206.25 and 1079.2% above the Healthcare Providers & Services industry median of 17.49. Medeze Group PCL's overall GF Score™ is 19/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Medeze Group PCL (BKK:MEDEZE), the current EV-to-FCF is 206.25 as of Sep. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Medeze Group PCL is engaged in the business of providing stem cell storage, analyzing, isolation, cultivation and preservation services for medical use. It is organised into four reportable segments: Stem cell sample collection service segment; White blood cell potential testing service segment; Other services segment and Sales of products segment. Geographically, the company operates in Thailand, Vietnam, Cambodia, Philippines, and Other countries, of which maximum revenue is derived from Thailand.
19GF Score
Get the complete analysis for BKK:MEDEZE
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:MEDEZE has been successfully added to your 
